IngMar Medical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • IngMar Medical's estimated annual revenue is currently $8.5M per year.(i)
  • IngMar Medical's estimated revenue per employee is $251,000

Employee Data

  • IngMar Medical has 34 Employees.(i)
  • IngMar Medical grew their employee count by 6% last year.

IngMar Medical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director EngineeringReveal Email/Phone
3
Director FinanceReveal Email/Phone
4
Director Product ManagementReveal Email/Phone
5
Director OperationsReveal Email/Phone
6
Clinical Education ManagerReveal Email/Phone
7
Human Resources ManagerReveal Email/Phone
8
Manager, Customer SuccessReveal Email/Phone
9
Mfg. ManagerReveal Email/Phone
10
PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$92.4M36826%N/AN/A
#2
$7M280%N/AN/A
#3
$46.2M18413%N/AN/A
#4
$2.6M21-78%$64.3MN/A
#5
$10.8M4316%N/AN/A
#6
$46.4M148-17%N/AN/A
#7
$26.1M10418%N/AN/A
#8
$26.9M1078%N/AN/A
#9
$40.7M1629%N/AN/A
#10
$38.9M15511%N/AN/A
Add Company

What Is IngMar Medical?

IngMar Medical's respiratory simulators and test lungs are used worldwide to provide hands-on clinician training, test ventilator performance, and accelerate research and development. Our ASL 5000 is the world’s most sophisticated breathing simulator – ”the gold standard” – and the only high fidelity neonatal breathing simulator available. Join the ASL 5000 Breathing Simulator User Forum, https://www.linkedin.com/groups/8157006. ISO 9001:2008 certification serves as a validation of our deep commitment to quality and customer satisfaction. Through our Internship Program we have employed more than 25 interns, primarily through a relationship with the RWTH-Aachen University in Germany.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$8.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.8M3410%N/A
#2
$7.9M34-3%N/A
#3
$6.7M343%N/A
#4
$3.5M3417%N/A
#5
$35M34-8%N/A